IBDEI1EX ; ; 01-FEB-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,22848,1,4,0)
 ;;=4^A63.0
 ;;^UTILITY(U,$J,358.3,22848,2)
 ;;=^5000360
 ;;^UTILITY(U,$J,358.3,22849,0)
 ;;=L84.^^76^982^1
 ;;^UTILITY(U,$J,358.3,22849,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22849,1,3,0)
 ;;=3^Callus
 ;;^UTILITY(U,$J,358.3,22849,1,4,0)
 ;;=4^L84.
 ;;^UTILITY(U,$J,358.3,22849,2)
 ;;=^271920
 ;;^UTILITY(U,$J,358.3,22850,0)
 ;;=L03.314^^76^982^24
 ;;^UTILITY(U,$J,358.3,22850,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22850,1,3,0)
 ;;=3^Cellulitis of Groin
 ;;^UTILITY(U,$J,358.3,22850,1,4,0)
 ;;=4^L03.314
 ;;^UTILITY(U,$J,358.3,22850,2)
 ;;=^5009050
 ;;^UTILITY(U,$J,358.3,22851,0)
 ;;=A63.0^^76^982^39
 ;;^UTILITY(U,$J,358.3,22851,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22851,1,3,0)
 ;;=3^Condyloma
 ;;^UTILITY(U,$J,358.3,22851,1,4,0)
 ;;=4^A63.0
 ;;^UTILITY(U,$J,358.3,22851,2)
 ;;=^5000360
 ;;^UTILITY(U,$J,358.3,22852,0)
 ;;=M71.30^^76^982^41
 ;;^UTILITY(U,$J,358.3,22852,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22852,1,3,0)
 ;;=3^Cyst,Digital Mucous
 ;;^UTILITY(U,$J,358.3,22852,1,4,0)
 ;;=4^M71.30
 ;;^UTILITY(U,$J,358.3,22852,2)
 ;;=^5013149
 ;;^UTILITY(U,$J,358.3,22853,0)
 ;;=D04.122^^76^982^7
 ;;^UTILITY(U,$J,358.3,22853,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22853,1,3,0)
 ;;=3^Carcinoma in Situ Skin Left Lower Eyelid
 ;;^UTILITY(U,$J,358.3,22853,1,4,0)
 ;;=4^D04.122
 ;;^UTILITY(U,$J,358.3,22853,2)
 ;;=^5157285
 ;;^UTILITY(U,$J,358.3,22854,0)
 ;;=D04.121^^76^982^9
 ;;^UTILITY(U,$J,358.3,22854,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22854,1,3,0)
 ;;=3^Carcinoma in Situ Skin Left Upper Eyelid
 ;;^UTILITY(U,$J,358.3,22854,1,4,0)
 ;;=4^D04.121
 ;;^UTILITY(U,$J,358.3,22854,2)
 ;;=^5157284
 ;;^UTILITY(U,$J,358.3,22855,0)
 ;;=D04.112^^76^982^14
 ;;^UTILITY(U,$J,358.3,22855,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22855,1,3,0)
 ;;=3^Carcinoma in Situ Skin Right Lower Eyelid
 ;;^UTILITY(U,$J,358.3,22855,1,4,0)
 ;;=4^D04.112
 ;;^UTILITY(U,$J,358.3,22855,2)
 ;;=^5157283
 ;;^UTILITY(U,$J,358.3,22856,0)
 ;;=D04.111^^76^982^16
 ;;^UTILITY(U,$J,358.3,22856,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22856,1,3,0)
 ;;=3^Carcinoma in Situ Skin Right Upper Eyelid
 ;;^UTILITY(U,$J,358.3,22856,1,4,0)
 ;;=4^D04.111
 ;;^UTILITY(U,$J,358.3,22856,2)
 ;;=^5157282
 ;;^UTILITY(U,$J,358.3,22857,0)
 ;;=L30.2^^76^982^40
 ;;^UTILITY(U,$J,358.3,22857,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22857,1,3,0)
 ;;=3^Cutaneous Autosensitization
 ;;^UTILITY(U,$J,358.3,22857,1,4,0)
 ;;=4^L30.2
 ;;^UTILITY(U,$J,358.3,22857,2)
 ;;=^5009155
 ;;^UTILITY(U,$J,358.3,22858,0)
 ;;=B07.0^^76^983^2
 ;;^UTILITY(U,$J,358.3,22858,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22858,1,3,0)
 ;;=3^Wart,Plantar
 ;;^UTILITY(U,$J,358.3,22858,1,4,0)
 ;;=4^B07.0
 ;;^UTILITY(U,$J,358.3,22858,2)
 ;;=^336720
 ;;^UTILITY(U,$J,358.3,22859,0)
 ;;=B07.8^^76^983^3
 ;;^UTILITY(U,$J,358.3,22859,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22859,1,3,0)
 ;;=3^Wart,Viral
 ;;^UTILITY(U,$J,358.3,22859,1,4,0)
 ;;=4^B07.8
 ;;^UTILITY(U,$J,358.3,22859,2)
 ;;=^5000518
 ;;^UTILITY(U,$J,358.3,22860,0)
 ;;=A63.0^^76^983^1
 ;;^UTILITY(U,$J,358.3,22860,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22860,1,3,0)
 ;;=3^Wart,Anogenital
 ;;^UTILITY(U,$J,358.3,22860,1,4,0)
 ;;=4^A63.0
 ;;^UTILITY(U,$J,358.3,22860,2)
 ;;=^5000360
 ;;^UTILITY(U,$J,358.3,22861,0)
 ;;=Z48.00^^76^983^4
 ;;^UTILITY(U,$J,358.3,22861,1,0)
 ;;=^358.31IA^4^2
